By Amalia Xeini, Associate, POTAMITISVEKRIS

In a dynamic environment, such as that of the pharmaceutical industry, R&D on new pharmaceutical products and therapies for the successful treatment of diseases is of strategic importance at both national and EU level^[1]. In this respect, pharmaceutical companies are investing significant funds in the research and development (R&D) of clinical trials.

Read more: Changes on Ongoing Clinical Trials during the Covid-19 Pandemic

By Alexander S. Kritikos, Research Director the German Institute for Economic Research (DIW Berlin) and Professor of Economics at the University of Potsdam

Published in Business File, June –July-August 2020, No 126, p. 22-23
 

Greece cannot take on another decade of slow economic progress. Professor Alexander S. Kritikos in this article points out that the current economic break, as terrible as it also is for all economic life, is a second chance for Greece. Now is the time to break up structures and put the country on a new economic foundation. To make Greece more competitive and innovative, not only are investments needed but also the structural reforms that have been delayed for a decade.

Read more: Hellas: From the Economic Crisis to the Corona Crisis Without a Pause

By Fotini Kardiopoulis, Partner, Attorney-at-Law, LL.M., Dr. Helen G. Papaconstantinou and Partners, Law Firm

Introduction.

Even though the necessary modifications introduced by EU Directive 2015/2436 were due to be transposed into national law by January 19, 2019, and notwithstanding the fact that the public consultation on a related draft law was finalized that month, the long-anticipated new trademark  law was only enacted in Greece on March 20, 2020,  in the midst of the Covid-19 lockdown. Law 4679/2020 finally transposed Directive (EU) 2015/2436 in Greece and efficiently approximates the treatment of the national trade mark to that of the EU trademark, as regulated by the EU Regulation 2017/1001.

Read more: Greece (finally!) introduces its new Trademark Law implementing the EU Directive

By Konstantina I.Tzerefou, Associate, Koutalidis Law Firm &

Christina Kechagia-Tsiakiri, LLM, Associate, Koutalidis Law Firm
 

1.       How was the arsenal of State aid rules been implemented to combat the economic and societal upheaval caused by COVID-19 at European level?

The recent outbreak of Coronavirus that placed global economy in turmoil necessitated an immediate response both at European and national level. Due to the pandemic, both the supply and demand channels have been severally disrupted, while there is a negative effect on investment plans and liquidity capacity. To mitigate the consequences of the pandemic, the European Commission decided to facilitate, under specific compatibility conditions, the granting of State aid by EU member states in support of firms that were “directly affected” by the COVID-19 situation.

Read more: State aid rules & the Greek State’s measures to support the economy

Αθήνα, 14 Ιουλίου 2020

Δελτίο Τύπου

13th Insurance Conference: Προοπτικές και προκλήσεις της ασφαλιστικής αγοράς

Θεσμικές παρεμβάσεις, σημαντικές ομιλίες, χρήσιμες προτάσεις και συμπεράσματα από κορυφαία στελέχη ανέδειξε το 13th Insurance Conference για το μέλλον της ασφαλιστικής αγοράς, που πραγματοποιήθηκε την Πέμπτη 9 & την Παρασκευή 10 Ιουλίου 2020. Τριάντα διακεκριμένοι ομιλητές από όλη την ασφαλιστική αγορά έθεσαν επί τάπητος τα προβλήματα που προκάλεσε η πανδημία στην ασφαλιστική αγορά, παρουσίασαν τη στρατηγική αντιμετώπισης της κρίσης και μοιράστηκαν τις εκτιμήσεις τους για την επόμενη μέρα, ενώ περισσότεροι από 630 σύνεδροι είχαν την ευκαιρία να χρησιμοποιήσουν τα εργαλεία της ψηφιακής πλατφόρμας LiveOn, η οποία παρέχει μια σύγχρονη διαδραστική εμπειρία στο χώρο των συνεδρίων.

Read more: 13th Insurance Conference: Προοπτικές και προκλήσεις της ασφαλιστικής αγοράς